Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.
Busse WW; Morgan WJ; Gergen PJ; Mitchell HE; Gern JE; Liu AH; Gruchalla RS; Kattan M; Teach SJ; Pongracic JA; Chmiel JF; Steinbach SF; Calatroni A; Togias A; Thompson KM; Szefler SJ; Sorkness CA; The New England Journal Of Medicine, 2011, vol. 364, issue 11, p 1005, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation